Results 241 to 250 of about 29,013 (278)

Infections in LVAD patients

Journal of Cardiac Surgery, 2022
Infections in left ventricular assist device (LVAD) patients remain common. Differentiating into device related and non-device related infection is crucial. The incidence of non-device related infections seems to be more determined by the overall condition of the LVAD recipient. Device related infections can be treated by innovative surgical approaches
Julia Bini Viotti, Yochiro Natori, Matthias Loebe   +2 more
openaire   +3 more sources

Etiology of Continuous-Flow LVAD (CF-LVAD) Infections

The Journal of Heart and Lung Transplantation, 2019
Purpose Infection is a frequent problem following CF-LVAD implantation. We were interested in determining the spectrum of infectious complications following implantation of HeartMate II (HMII) and Heartware (HW) CF-LVADs. Methods We reviewed 893 HMII and HW implants from 1999 to 2018 performed at our institution.
N. Wang, J.K. Ho, F.I. Musfee, H.K. Lamba, F.H. Cheema, D.A. Taylor, L.C. Sampaio, J.A. Morgan, G. Loor, O.H. Frazier, G.V. Letsou   +10 more
openaire   +1 more source

LVAD Inpatient Management

2021
While the evolution of LVAD pump design and management has achieved increased clinical experience and significantly improved 1-year survival rates [1], patients remain at high risk for complications in the immediate perioperative period including thromboembolic events, bleeding, right heart failure, and driveline associated infections.
Johannes Steiner, Hao A. Tran
openaire   +1 more source

LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection

The Journal of Heart and Lung Transplantation, 2003
Patients who have ventricular assist devices (VADs) and experience bloodstream infection (BSI) have high mortality. We addressed 2 questions raised by the United Network for Organ Sharing (UNOS) priority policy for this problem: 1) Are organs wasted on this ultra-high-risk group?
Robert S, Poston, Shahid, Husain, Damian, Sorce, Ellieen, Stanford, Shimon, Kusne, Margaret, Wagener, Bartley P, Griffith, Robert L, Kormos   +7 more
openaire   +2 more sources

Third-Generation LVADs

Cardiology in Review, 2019
The field of durable left ventricular assist devices has advanced dramatically since its introduction into the clinical realm. From the first-generation pulsatile HeartMate XVE device to the second-generation continuous axial flow HeartMate-2 to the current third-generation centrifugal flow devices, the left ventricular assist device has undergone ...
Avi, Levine, Alan, Gass
openaire   +2 more sources

Discontinuing the LVAD: Ethical considerations

The Annals of Thoracic Surgery, 1997
T he deve lopment of implantable left ventr icular assist devices (LVADs) opens new vistas in pat ient care, while s imul taneous ly drawing at tention to ethical problems in the use of such technology. Such ethical questions include when and under what condit ions we ought to start, stop, or refrain from init iat ing t rea tment with such a device. We
T P, Powell, M C, Oz
openaire   +2 more sources

Defining LVAD Success: A Nationwide Survey of LVAD Program Team Members

The Journal of Heart and Lung Transplantation, 2020
Purpose The purpose of this study was to determine how LVAD success is defined by LVAD team members across the United States. Methods An online, anonymous survey was shared with 32 LVAD programs across the country. Six case vignettes were provided: 1) young active drug user 2) demanding patient 3) medically complicated patient 4) socially isolated
R. Cogswell, A.El Rafei, J. Cowger, S. Joseph, J. Schultz, J. Estep, R. John, P. Eckman   +7 more
openaire   +1 more source

Jarvik 2000 LVAD

2003
Der Mangel an Spenderherzen erfordert die Entwicklung von alternativen Therapien der terminalen Herzinsuffizienz. Das Jarvik 2000 Linksherzunterstuztungssystem (LVAD) (4, 12) ist eine neuartige axiale Flusspumpe, welche fur die Langzeitunterstutzung konzipiert wurde (Abb.1 und 2).
Siegenthaler, Michael P., Gutwald, Ralf Jochen, Schmelzeisen, Rainer, Beyersdorf, Friedhelm   +3 more
openaire   +2 more sources

Oxygenator in short-term LVAD circuit: a rescue in post-LVAD pulmonary complications

Perfusion, 2016
Pulmonary complications after left ventricular assist device (LVAD) implantation, though infrequent, can be potentially catastrophic. A 62-year-old female with cardiogenic shock, supported on short-term LVAD, developed pulmonary oedema. An oxygenator was introduced into the LVAD circuit, which improved the gas exchange and, eventually, after weaning ...
Prashant N, Mohite, Nikhil P, Patil, Aron-Frederik, Popov, Toufan, Bahrami, Andre R, Simon   +4 more
openaire   +2 more sources

LVAD

The Nurse Practitioner, 2014
Heart failure affects more than 5 million Americans with approximately 200,000 patients in end-stage disease that has failed traditional treatment. Historically, the only option for treatment was a heart transplant until left ventricular assist devices offered another option.
openaire   +2 more sources